Ibrutinib,Tisagenlecleucel
janssen,novartis,abbvie
['mantle,(-dismantle)', 'tisagenlecleucel', ' ibru', 'universal', 'tarmac', 'tisa-cel', '2019', '2018', 'lymphoma', 'lymsm']
. presents the biological &amp; clinical rationale for the tarmac trial, combining ibrutinib with tisa-cel in patients with r/r mantle-cell lymphoma #lymsm #ash22 #tcellrx 
haematology registrar | fellow @PORTAL_research @harvardmed |
evidence-based medicine | health policy | lymphoma | myeloma |
Fulbright scholar | muso | writer